Ondansetron 8 mg tablets are a prescription anti-nausea medication (brand name Zofran®) used to prevent or treat vomiting and nausea. Each tablet contains 8 mg of ondansetron, a serotonin 5-HT₃ receptor antagonist that blocks the action of serotonin – a natural substance that can trigger vomiting. By blocking those receptors in the gut and brain, ondansetron stops nausea/vomiting signals. It is chiefly used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. Patients usually take an 8 mg tablet by mouth shortly before chemotherapy or surgery (as directed by a doctor) to reduce the chance of vomiting.
Ondansetron Tablets are commonly used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. They work by blocking the action of serotonin, a natural substance that may trigger nausea and vomiting. Ondansetron is an effective antiemetic, improving patient comfort and treatment compliance, especially during cancer treatments. The use of Ondansetron is essential in managing side effects of aggressive treatments and enhancing the quality of life for patients undergoing medical procedures.
Experience swift and effective relief from nausea and vomiting with Ondansetron Tablets 8 mg by Aurobindo Pharma. Expertly formulated to address these uncomfortable symptoms, ondansetron is a trusted name in antiemetic therapy. Each bottle contains 30 precisely dosed tablets, ensuring consistent management for patients undergoing chemotherapy, radiation therapy, or surgery.
Details and Features:
Brand: Aurobindo Pharma
Dosage Form: Oral tablets
Strength: 8 mg per tablet
Quantity: 30 tablets per bottle
Active Ingredient: Ondansetron hydrochloride
Usage: Antiemetic – for the prevention of nausea and vomiting
Quality Assurance: Manufactured following pharmaceutical industry standards to ensure safety and efficacy
Mechanism of Action:
Ondansetron works by selectively blocking serotonin 5-HT3 receptors located in the central nervous system and peripheral nervous system. By inhibiting the action of serotonin (a natural substance in the body that can cause vomiting), ondansetron effectively reduces the stimulation of the vomiting center in the brain, providing potent relief from nausea and vomiting.
Directions for Use:
1. Take ondansetron tablets exactly as prescribed by your healthcare provider.
2. The standard dosage for adults is 8 mg taken orally, typically 30 minutes before the start of chemotherapy, radiation therapy, or surgery.
3. Follow with a subsequent 8 mg dose every 8 hours as directed by your healthcare provider.
4. Swallow tablets whole with a glass of water; do not crush or chew.
5. Adherence to the prescribed schedule improves effectiveness.
Warnings:
This medication should be used under the supervision of a healthcare provider.
Do not take ondansetron if you have a known hypersensitivity to the drug or its ingredients.
- Notify your doctor if you have a history of heart issues, as ondansetron can cause heart-related side effects in susceptible individuals.
- Pregnant or breastfeeding women should seek medical advice before using this medication.
- Store in a cool, dry place, away from direct sunlight, and keep out of reach of children.
Side Effects:
Ondansetron is generally well tolerated, but some individuals may experience side effects. Common side effects include:
- Headache
- Dizziness
- Constipation
- Fatigue
Rare, but serious side effects that require immediate medical attention include:
- Allergic reactions (swelling of the face, lips, or throat, hives)
- Changes in heart rhythm (such as rapid or irregular heartbeat)
- Significantly low blood pressure
- Unusual mood changes
Always consult a healthcare professional if you experience any concerning symptoms or need clarification regarding the use of Ondansetron Tablets 8 mg. Aurobindo Pharma is committed to quality and safety, ensuring you have access to effective relief from nausea and vomiting for improved health and well-being.
Ondansetron (Zofran) 8 mg tablets are oral anti-nausea medicines used to prevent chemotherapy-, radiation- or surgery-related vomiting. The dosage depends on the indication and patient age (see below). In all cases, the total daily dose should not exceed 32 mg in adults.
-
Chemotherapy-induced nausea (adults):
- Moderately emetogenic chemo: Take 8 mg by mouth 30–120 minutes before chemotherapy, then 8 mg again 8 hours later, and continue 8 mg twice daily (every 12 hours) for 1–2 days after finishing chemo.
- Highly emetogenic chemo (e.g. high-dose cisplatin): A one-time dose of 24 mg orally (often given with 12 mg dexamethasone) 1–2 hours before chemo is used. (This 24 mg dose equals three 8 mg tablets.) Subsequent doses of ondansetron or other antiemetics may follow per guidelines.
- Total 24-hour limit: Do not exceed 32 mg/day in adults (e.g. four 8 mg doses), per prescribing guidance.
-
Radiation-induced nausea (adults): Give 8 mg orally about 1–2 hours before each radiotherapy session. For example: 8 mg three times a day on days of total-body irradiation or daily abdominal radiation. (In practice: 8 mg 1–2 h pre-treatment, then 8 mg every 8 hours for 1–2 days after, as needed.
-
Postoperative nausea (PONV) – adults: For prevention, take 16 mg orally 1 hour before anesthesia induction (two 8 mg tablets). This single 16 mg dose is standard for PONV prophylaxis. (If nausea/vomiting occurs after surgery, intravenous ondansetron is usually given instead.)
-
Pediatric patients:
- Ages 12–17 years: Use adult dosing regimens (e.g. 8 mg before chemo ± repeat dosing). Tablets may be given whole or split if needed.
- Ages 4–11 years: The usual dose is 4 mg by mouth (often as a single 4 mg tablet or half of an 8 mg tablet) three times a day for chemo-induced nausea. (Give the first 4 mg dose 30 minutes before chemo, then at 4 and 8 hours after; continue 4 mg every 8 hours once daily for 1–2 days post-chemo). Children in this age group rarely receive 8 mg at once.
- Under 4 years: Oral ondansetron tablets are not approved; use IV ondansetron if needed in infants/younger children.
-
Special populations: No dose adjustment is needed for renal impairment or for most elderly patients. However, in severe liver disease, clearance is reduced; the total daily dose should be limited to 8 mg per day (for example, 8 mg once daily).
-
Administration: Swallow the 8 mg tablet with water (it can be taken with or without food). For nausea control, timing is important – e.g. before chemo sessions or anesthesia as specified. Do not exceed recommended doses; spacing repeat doses by at least 8–12 hours is typical (see above schedules) to avoid overdose.
Sources: These dosing regimens come from the official prescribing information and drug guides. For example, the UK SmPC and FDA label note 8 mg orally 1–2 hours before chemo/radiation, then 8 mg every 12 hours for up to 5 days; for highly emetogenic chemo, a single 24 mg dose is used. For postoperative nausea, guidelines specify 16 mg once before anesthesia. Pediatric dosing (4 mg in kids 4–11 years, 8 mg for teens) is detailed in clinical references. Renal/elderly dosing notes and the 32 mg/day limit appear in product labels. These authoritative sources ensure accurate dosing information.
Ondansetron Side Effects
Common side effects: Ondansetron tablets are generally well tolerated, but many people experience mild effects. The most frequently reported side effect is headache. (occurring in more than 1 in 10 patients). Other common effects (up to ~10% of users) include a sense of warmth or flushing and constipation.. Some people may also notice mild dizziness or feeling tired. (Transient changes in liver function tests have been reported, especially when ondansetron is given with certain chemotherapy drugs.
Less common side effects: Less often (up to about 1 in 100 patients) ondansetron can cause symptoms like hiccups, a drop in blood pressure (which can make you feel faint or dizzy), irregular heartbeats, chest pain, seizures (fits), or involuntary muscle movements. For example, feeling lightheaded when standing up or minor ECG changes have been seen. These effects are uncommon but worth noting.
Rare but serious effects: In rare cases (less than 1 in 1,000), ondansetron can cause severe dizziness/lightheadedness, blurred vision, or significant heart-rhythm disturbances (sometimes leading to fainting). Very rarely (≈1 in 10,000), it can cause a transient loss of vision. The patient information leaflet warns that chest pain may occur, possibly related to heart effects. Because ondansetron can affect the heart’s electrical rhythm (QT interval), patients with heart disease are monitored closely.
Allergic reactions: Although uncommon, any sign of an allergic response requires stop of the drug and urgent care. Symptoms of a serious hypersensitivity reaction include rash or hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing, and sudden chest tightness. If these appear after taking ondansetron, treatment should be discontinued immediately.
In summary, ondansetron 8 mg tablets can cause mostly mild side effects like headache, constipation, and flushing. Serious side effects are rare but important: heart-rhythm problems (palpitations, fainting) and allergic reactions are the most critical. Patients should report any severe or unusual symptoms (such as chest pain, severe dizziness or rash) to their doctor promptly.
